These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11264186)

  • 1. Stroke in hemoglobin (SD) sickle cell disease with moyamoya: successful hydroxyurea treatment after cerebrovascular bypass surgery.
    Schmugge M; Frischknecht H; Yonekawa Y; Baumgartner RW; Boltshauser E; Humbert J
    Blood; 2001 Apr; 97(7):2165-7. PubMed ID: 11264186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined blood transfusion and hydroxycarbamide in children with sickle cell anaemia.
    Brousse V; Gandhi S; de Montalembert M; Height S; Dick MC; O'Driscoll S; Abihsera G; Rees DC
    Br J Haematol; 2013 Jan; 160(2):259-61. PubMed ID: 23116405
    [No Abstract]   [Full Text] [Related]  

  • 3. Encephaloduroarteriosynangiosis and encephalomyoarteriosynangiosis for treatment of moyamoya syndrome in pediatric patients with sickle cell disease.
    Griessenauer CJ; Lebensburger JD; Chua MH; Fisher WS; Hilliard L; Bemrich-Stolz CJ; Howard TH; Johnston JM
    J Neurosurg Pediatr; 2015 Jul; 16(1):64-73. PubMed ID: 25837886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in Understanding Ischemic Stroke Physiology and the Impact of Vasculopathy in Children With Sickle Cell Disease.
    Guilliams KP; Fields ME; Dowling MM
    Stroke; 2019 Feb; 50(2):266-273. PubMed ID: 30661504
    [No Abstract]   [Full Text] [Related]  

  • 5. Cerebral Revascularization for Moyamoya Syndrome Associated with Sickle Cell Disease: A Systematic Review of the Literature on the Role of Extracranial-Intracranial Bypass in Treating Neurologic Manifestations of Pediatric Patients with Sickle Cell Disease.
    Terrell D; Savardekar AR; Whipple SG; Dossani RH; Spetzler RF; Sun H
    World Neurosurg; 2020 May; 137():62-70. PubMed ID: 32014541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EC-IC bypass improves chronic ischemia in a patient with moyamoya disease secondary to sickle cell disease: an in vivo microdialysis study.
    Mendelowitsch A; Sekhar LN; Clemente R; Shuaib A
    Neurol Res; 1997 Feb; 19(1):66-70. PubMed ID: 9090639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cautionary note regarding hydroxyurea in sickle cell disease.
    Vichinsky EP; Lubin BH
    Blood; 1994 Feb; 83(4):1124-8. PubMed ID: 7509209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pragmatic anesthetic approach for extracranial to intracranial bypass surgery in a patient with moyamoya disease and sickle cell disease: a case report.
    Lal S; Larney V
    J Med Case Rep; 2023 Mar; 17(1):136. PubMed ID: 36998062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of Extracranial Internal Carotid Artery Disease in Children With Sickle Cell Anemia.
    Verlhac S; Ithier G; Bernaudin F; Oloukoi C; Cussenot I; Balandra S; Kheniche A; Ntorkou A; Ouaziz H; Tanase A; Sekkal A; Belarbi N; Elmaleh M; Alison M
    Stroke; 2022 Aug; 53(8):2637-2646. PubMed ID: 35387492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moyamoya syndrome in childhood sickle cell disease: a predictive factor for recurrent cerebrovascular events.
    Dobson SR; Holden KR; Nietert PJ; Cure JK; Laver JH; Disco D; Abboud MR
    Blood; 2002 May; 99(9):3144-50. PubMed ID: 11964276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of surgical revascularization for stroke prevention in pediatric patients with sickle cell disease and moyamoya syndrome.
    Yang W; Xu R; Porras JL; Takemoto CM; Khalid S; Garzon-Muvdi T; Caplan JM; Colby GP; Coon AL; Tamargo RJ; Huang J; Ahn ES
    J Neurosurg Pediatr; 2017 Sep; 20(3):232-238. PubMed ID: 28686127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical treatment of moyamoya syndrome in patients with sickle cell anemia: outcome following encephaloduroarteriosynangiosis.
    Hankinson TC; Bohman LE; Heyer G; Licursi M; Ghatan S; Feldstein NA; Anderson RC
    J Neurosurg Pediatr; 2008 Mar; 1(3):211-6. PubMed ID: 18352765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracranial-intracranial bypass for symptomatic occlusive cerebrovascular disease not amenable to carotid endarterectomy.
    Tummala RP; Chu RM; Nussbaum ES
    Neurosurg Focus; 2003 Mar; 14(3):e8. PubMed ID: 15709725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrovascular events in sickle cell-beta thalassemia treated with hydroxyurea: a single center prospective survey in adult Italians.
    Rigano P; Pecoraro A; Calvaruso G; Steinberg MH; Iannello S; Maggio A
    Am J Hematol; 2013 Nov; 88(11):E261-4. PubMed ID: 23828131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral revascularization surgery reduces cerebrovascular events in children with sickle cell disease and moyamoya syndrome: Results of the stroke in sickle cell revascularization surgery retrospective study.
    Aldana PR; Hanel RA; Piatt J; Han SH; Bansal MM; Schultz C; Gauger C; Pederson JM; Iii JCW; Hulbert ML; Jordan LC; Qureshi A; Garrity K; Robert AP; Hatem A; Stein J; Beydler E; Adelson PD; Greene S; Grabb P; Johnston J; Lang SS; Leonard J; Magge SN; Scott A; Shah S; Smith ER; Smith J; Strahle J; Vadivelu S; Webb J; Wrubel D
    Pediatr Blood Cancer; 2023 Jul; 70(7):e30336. PubMed ID: 37057741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral Hyperperfusion Syndrome by the Numbers: Transient Focal Neurological Deficit, Imaging-Proven Focal Hyperperfusion, and High Graft Flow Rate Following Superficial Temporal Artery-Middle Cerebral Artery bypass in a Patient With Symptomatic Carotid Occlusion-Case Report.
    Rahme R; Sudhakar TD; Alimi M; White TG; Ortiz RA; Langer DJ
    Oper Neurosurg (Hagerstown); 2018 Dec; 15(6):E94-E99. PubMed ID: 29514319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracranial carotid artery stent placement causes delayed severe intracranial hemorrhage in a patient with moyamoya disease.
    Eicker S; Etminan N; Turowski B; Steiger HJ; Hänggi D
    J Neurointerv Surg; 2011 Jun; 3(2):160-2. PubMed ID: 21990810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxyurea lowers transcranial Doppler flow velocities in children with sickle cell anaemia in a Nigerian cohort.
    Lagunju I; Brown BJ; Sodeinde O
    Pediatr Blood Cancer; 2015 Sep; 62(9):1587-91. PubMed ID: 25847050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Moyamoya disease as a cause of ischemic cerebral stroke in young people].
    Borowik H; Pogorzelski R; Drozdowski W
    Przegl Lek; 2006; 63(8):691-4. PubMed ID: 17441385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moyamoya disease associated with hereditary spherocytosis.
    Vo Van P; Sabouraud P; Mac G; Abely M; Bednarek N
    Pediatr Neurol; 2011 Jan; 44(1):69-71. PubMed ID: 21147392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.